Associate Director of Clinical Trials at The Cancer Institute of New Jersey Given National Award
New Brunswick, N.J. – Susan Goodin, PharmD, FCCP, BCOP, associate director of clinical trials and therapeutics at The Cancer Institute of New Jersey (CINJ) has received the 2012 Award of Excellence from the Hematology/Oncology Pharmacy Association (HOPA). CINJ is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.
HOPA is a national professional organization dedicated to supporting hematology/oncology pharmacy practitioners in optimizing cancer patient care. The association recognized Dr. Goodin for making a significant, sustained contribution to hematology/oncology pharmacy and for providing leadership in supporting or improving this area.
Goodin, who is also a professor of medicine at UMDNJ-Robert Wood Johnson Medical School, leads CINJ's clinical trials program and since 1993 has served as director of CINJ's Division of Pharmaceutical Sciences. It is in this capacity that she oversees the pharmacy team that provides medications for patients and educates those patients about usage, pain management and other related aspects. An active researcher, Goodin also studies investigational drugs via clinical trials and promotes the importance of such study as a way to help researchers unlock the mysteries of cancer.
The Cranford resident received the award during the association's 2012 annual meeting being held this week.
About The Cancer Institute of New Jersey
The Cancer Institute of New Jersey (www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated to improving the detection, treatment and care of patients with cancer, and serving as an education resource for cancer prevention. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life. To make a tax-deductible gift to support CINJ, call 732-235-8614 or visit www.cinjfoundation.org. CINJ is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School. Follow us on Facebook at www.facebook.com/TheCINJ.
The CINJ Network is comprised of hospitals throughout the state and provides the highest quality cancer care and rapid dissemination of important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. System Partner: Meridian Health (Jersey Shore University Medical Center, Ocean Medical Center, Riverview Medical Center, Southern Ocean Medical Center, and Bayshore Community Hospital). Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Medical Center, Carol G. Simon Cancer Center at Overlook Medical Center, and Cooper University Hospital. Affiliate Hospitals: CentraState Healthcare System, JFK Medical Center, Robert Wood Johnson University Hospital Hamilton (CINJ Hamilton), Somerset Medical Center, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton. *Academic Affiliate